Founded
2017
After two decades of studying health interventions, the founders pinpointed a gap in scalable medication management solutions. Together they and their earliest employees built an AI-driven platform that combined clinical expertise with data science.
Commercialization
2019
The team brings the Arine Platform to the market, with a focus on reaching those in greatest need by initially launching with a Medicaid plan.
Results
2020
Arine reduces cost of care by 15%, reduces hospitalizations by 40%, and achieves +3 Stars improvement for health plans to 5 Stars.
Series A
2021
Arine raises $11M in series A and continues to impact cost and quality for major health plans.
Series B
2022
Arine raises $29M in series B funding and announces partnerships with several health plans, including Priority Health and Blue Shield of California, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.
Growth
2023
The team experiences significant growth in 2023 and increases its revenue by 100%. Arine’s account portfolio includes more than 30 health plans overall.
Expansion
2024
Arine is recognized by Inc. 5000 among America’s Fastest-Growing Companies, ranking 236 overall and 5th in AI. Our growth is driven by strong partnerships, including five leading national health plans and seven Blues plans. To date, we’ve positively impacted over 20 million lives and produced more than 40 million life-enhancing recommendations annually.